Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Guided Therapeutics (GTHP) Treasury Shares (2016 - 2025)

Guided Therapeutics' Treasury Shares history spans 16 years, with the latest figure at $132000.0 for Q3 2025.

  • On a quarterly basis, Treasury Shares changed 0.0% to $132000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $132000.0, a 0.0% change, with the full-year FY2024 number at $132000.0, changed 0.0% from a year prior.
  • Treasury Shares hit $300000.0 in Q4 2025 for Guided Therapeutics, down from $678000.0 in the prior quarter.
  • Over the last five years, Treasury Shares for GTHP hit a ceiling of $678000.0 in Q2 2021 and a floor of $300000.0 in Q4 2025.
  • Historically, Treasury Shares has averaged $652800.0 across 5 years, with a median of $678000.0 in 2021.
  • The widest YoY moves for Treasury Shares: up 0.0% in 2021, down 0.0% in 2021.
  • Tracing GTHP's Treasury Shares over 5 years: stood at $132000.0 in 2021, then changed by 0.0% to $132000.0 in 2022, then changed by 0.0% to $132000.0 in 2023, then changed by 0.0% to $132000.0 in 2024, then changed by 0.0% to $132000.0 in 2025.
  • Business Quant data shows Treasury Shares for GTHP at $132000.0 in Q3 2025, $132000.0 in Q2 2025, and $132000.0 in Q1 2025.